ArticleBMC public health2025
Global, regional, and national bladder cancer burden from 1990 to 2021 and forecasts to 2050: a systematic analysis of the global disease burden study in 2021.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic Impact of the Gustave Roussy Immune Score on Cancer-Specific Survival and Treatment Completion in Patients with Bladder Cancer.Diagnostics (Basel, Switzerland) · 2026Article
- Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundBladder cancer (BCa) remains a global health challenge, marked by geographic variations and evolving epidemiology. Despite new therapies, comprehensive assessments of long-term trends, risk factors, and predictive modeling are scarce. This study aimed to quantify the global, regional, and national burden of BCa in 2021, with stratification by age, sex, and geography. We further assessed temporal trends from 1990 to 2021 and projected future prevalence and mortality up to 2050. Finally, we analyzed demographic and regional disparities to identify high-risk populations and inform targeted prevention and resource allocation.
methodsWe utilized sex/age-stratified global registry data (29,377 sources) to model mortality via Bayesian spatiotemporal smoothing and incidence through hierarchical regression. DALYs were calculated by integrating mortality and disability using standardized life tables. Multilevel Bayesian age-period-cohort models, incorporating UN population projections and metabolic risk trajectories, generated 2050 estimates, with uncertainty quantified through 1,000 bootstrap replicates.
resultsIn 2021, global BCa prevalence was 540,310 cases (95% UI: 494,721-582,579), with an age-standardized prevalence of 0.00635%. Geographic variations were marked: Western Europe reached 0.078% (95% CI: 0.073-0.083%), with six countries exceeding 0.08%, while the United States had the highest at 0.101% (95% CI: 0.095-0.105%), with 31 states surpassing 0.1%. Males bore a substantially higher burden (sex ratio 4.2), with prevalence peaking in ages 85-89 (0.308%, 95% UI: 0.264-0.334%). From 1990 to 2021, the global age-standardized prevalence increased by 4% (95% UI: 2-14%).
conclusionBCa continues to exert a rising and uneven global burden. Temporal analyses revealed heterogeneous trends across regions, while projections indicate sustained increases by 2050, particularly in aging populations and resource-limited settings. Marked disparities by sex, age, and geography highlight high-risk groups requiring targeted interventions. These findings provide critical evidence to inform global health planning and prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.